Internet-based Cognitive Behavioral Therapy: a Factorial Randomized Controlled Trial About Treatment Content and Support
Tailored or Transdiagnostic ICBT with a Specific Therapist or Team Support: a Factorial Randomized Controlled Trial
1 other identifier
interventional
176
1 country
2
Brief Summary
The purpose of this study is to investigate the differences in treatment outcomes between individually tailored and transdiagnostic internet-based cognitive behavioral therapy (ICBT), as well as the differences between weekly support by a specific therapist and weekly support by a team. The target group is adults (18 years or older) who experience mild to moderate depression symptoms, anxiety, stress or other psychological symptoms. The ICBT, in both types of treatment contents, consists of modules that the participants will work with for eight weeks in total. Participants will be recruited in Sweden with nationwide recruitment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedStudy Start
First participant enrolled
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedOctober 9, 2024
October 1, 2024
3 months
January 8, 2024
October 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Becks Depression Inventory-II
Measure of depressive symptoms. Range for the total sum is between 0 and 63 with a higher score indicating a higher level of depressive symptoms. Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points respectively.
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Beck Anxiety Inventory
Measure of anxiety symptoms, consisting of 21 items. Range for the total sum is between 0 and 63, interpreted as minimal anxiety (0-7), mild anxiety (8-15), moderate anxiety (16-25) and severe anxiety (26-63).
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Secondary Outcomes (8)
Perceived Stress Scale-14
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Insomnia Severity Index
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Alcohol Use Disorder Identification Test
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Brunnsviken Brief Quality of Life Scale
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Patient Health Questionnaire-15
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
- +3 more secondary outcomes
Other Outcomes (1)
Knowledge test (created by the research team)
Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.
Study Arms (4)
Unified Protocol, support by a specific therapist
EXPERIMENTALThe participants receive eight weeks of ICBT, based on the treatment manual Unified Protocol by David Barlow and colleagues (2013), with weekly support by a specific therapist that follow the individual participant through all treatment weeks. During the eight weeks, the participant will receive in total eight treatment modules.
Unified Protocol, support by a team
EXPERIMENTALThe participants receive eight weeks of ICBT, based on the treatment manual Unified Protocol by David Barlow and colleagues (2013), with weekly support by a team of therapists. This arm implies that the participant will get support from different therapists each week. During the eight weeks, the participant will receive in total eight treatment modules.
Individually tailored treatment, support by a specific therapist
EXPERIMENTALThe participants receive ICBT in an individually tailored format, where they get to select which modules they want to be included in their specific treatment. The participants are recommended to select eight modules (out of 25) and work with one modules each week, but this is only recommendations. In their treatment, weekly support by a specific therapist that follow the individual participant through all treatment weeks is included.
Individually tailored treatment, support by team
EXPERIMENTALThe participants receive ICBT in an individually tailored format, where they get to select which modules they want to be included in their specific treatment. The participants are recommended to select eight modules (out of 25) and work with one modules each week, but this is only recommendations. In their treatment, weekly support by a team of therapists is included. This arm implies that the participant will get support from different therapists each week.
Interventions
All participants get treatment and are thus included in experimental groups, no matter the randomization result. It consists of eight treatment weeks with weekly support. The treatment format will differ between the four groups, depending on type of treatment content and type of support.
Eligibility Criteria
You may qualify if:
- Experience mild to moderate psychological symptoms or problems
- years or older
- Ability to speak, read and write in Swedish
- Have access to the internet and a smartphone, computer or other device
You may not qualify if:
- Severe psychiatric or somatic illness that makes participation harder or impossible
- Ongoing addiction
- Acute suicidality
- Other ongoing psychological treatment
- Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Linköping University
Linköping, Sweden
Department of Behavioral Sciences and Learning
Linköping, Östergörland, 58183, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerhard Andersson, PhD
University Hospital, Linkoeping
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 17, 2024
Study Start
January 8, 2024
Primary Completion
April 8, 2024
Study Completion
April 30, 2026
Last Updated
October 9, 2024
Record last verified: 2024-10